| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidyltransferase activity | 5.30e-11 | 6 | 125 | 5 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 5.30e-11 | 6 | 125 | 5 | GO:0002951 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 4.89e-10 | 8 | 125 | 5 | GO:0103068 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 1.10e-09 | 9 | 125 | 5 | GO:0036374 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 3.67e-08 | 16 | 125 | 5 | GO:0008242 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 1.28e-07 | 20 | 125 | 5 | GO:0070003 | |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 4.00e-10 | 8 | 124 | 5 | GO:0019344 | |
| GeneOntologyBiologicalProcess | peptide modification | 1.78e-09 | 10 | 124 | 5 | GO:0031179 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 1.78e-09 | 10 | 124 | 5 | GO:1901750 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 3.25e-09 | 11 | 124 | 5 | GO:0006751 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 5.54e-09 | 12 | 124 | 5 | GO:1901748 | |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 3.00e-08 | 16 | 124 | 5 | GO:0006534 | |
| GeneOntologyBiologicalProcess | peptide biosynthetic process | 4.90e-08 | 34 | 124 | 6 | GO:0043043 | |
| GeneOntologyBiologicalProcess | glutathione biosynthetic process | 1.04e-07 | 20 | 124 | 5 | GO:0006750 | |
| GeneOntologyBiologicalProcess | sulfur amino acid biosynthetic process | 1.36e-07 | 21 | 124 | 5 | GO:0000097 | |
| GeneOntologyBiologicalProcess | nonribosomal peptide biosynthetic process | 1.76e-07 | 22 | 124 | 5 | GO:0019184 | |
| GeneOntologyBiologicalProcess | leukotriene biosynthetic process | 1.76e-07 | 22 | 124 | 5 | GO:0019370 | |
| GeneOntologyBiologicalProcess | serine family amino acid biosynthetic process | 3.49e-07 | 25 | 124 | 5 | GO:0009070 | |
| GeneOntologyBiologicalProcess | peptide metabolic process | 7.39e-07 | 84 | 124 | 7 | GO:0006518 | |
| GeneOntologyBiologicalProcess | sulfur compound catabolic process | 7.62e-07 | 53 | 124 | 6 | GO:0044273 | |
| GeneOntologyBiologicalProcess | glutathione metabolic process | 2.15e-06 | 63 | 124 | 6 | GO:0006749 | |
| GeneOntologyBiologicalProcess | modified amino acid catabolic process | 2.71e-06 | 37 | 124 | 5 | GO:0042219 | |
| GeneOntologyBiologicalProcess | sulfur amino acid metabolic process | 4.03e-06 | 40 | 124 | 5 | GO:0000096 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 4.56e-06 | 41 | 124 | 5 | GO:0006691 | |
| GeneOntologyBiologicalProcess | serine family amino acid metabolic process | 5.81e-06 | 43 | 124 | 5 | GO:0009069 | |
| GeneOntologyBiologicalProcess | fatty acid derivative biosynthetic process | 1.50e-05 | 52 | 124 | 5 | GO:1901570 | |
| GeneOntologyBiologicalProcess | modified amino acid biosynthetic process | 1.50e-05 | 52 | 124 | 5 | GO:0042398 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.99e-05 | 313 | 124 | 10 | GO:0098742 | |
| GeneOntologyBiologicalProcess | icosanoid biosynthetic process | 5.19e-05 | 67 | 124 | 5 | GO:0046456 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid biosynthetic process | 5.98e-05 | 69 | 124 | 5 | GO:0170038 | |
| GeneOntologyBiologicalProcess | L-amino acid biosynthetic process | 6.41e-05 | 70 | 124 | 5 | GO:0170034 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | TARM1 PRTG DOCK8 L1CAM CELA2A SHB FNDC3A TENM2 CLDN10 CLDN8 CD84 FAT2 VPS33B PTPRR CD33 NINJ2 ADGRL3 CDH13 | 7.79e-05 | 1077 | 124 | 18 | GO:0098609 |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 8.70e-05 | 39 | 124 | 4 | GO:1903514 | |
| GeneOntologyBiologicalProcess | alpha-amino acid biosynthetic process | 1.01e-04 | 77 | 124 | 5 | GO:1901607 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 1.36e-04 | 82 | 124 | 5 | GO:1901568 | |
| GeneOntologyBiologicalProcess | amino acid biosynthetic process | 1.71e-04 | 86 | 124 | 5 | GO:0008652 | |
| GeneOntologyBiologicalProcess | modified amino acid metabolic process | 3.54e-04 | 218 | 124 | 7 | GO:0006575 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | TARM1 ABI3BP DOCK8 CORO1C L1CAM CELA2A SHB VPS33B PTPRR KIF14 SEMA6A PEAK1 DMD UTRN CDH13 | 4.53e-04 | 927 | 124 | 15 | GO:0030155 |
| GeneOntologyBiologicalProcess | somatic muscle development | 5.29e-04 | 6 | 124 | 2 | GO:0007525 | |
| GeneOntologyBiologicalProcess | amide biosynthetic process | 6.11e-04 | 172 | 124 | 6 | GO:0043604 | |
| GeneOntologyBiologicalProcess | cell junction assembly | ERBB4 ABI3BP HIPK1 CORO1C L1CAM CLDN10 CLDN8 SETD5 PEAK1 ADGRL3 CDH13 | 6.50e-04 | 569 | 124 | 11 | GO:0034329 |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | WWP2 CLDN10 RYR2 ITPR1 CD84 KCNJ16 METTL21C SCN10A DMD UTRN CLEC4C | 7.29e-04 | 577 | 124 | 11 | GO:0043269 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | GGTLC2 GGT2P KLHL20 MOSPD1 GGT1 GGT3P ITPR1 VPS33B RHPN2 PTPRR GGTLC1 BRI3 DMD TRAPPC2L CDH13 | 4.65e-04 | 934 | 125 | 15 | GO:0048471 |
| GeneOntologyCellularComponent | lamellipodium | 4.73e-04 | 230 | 125 | 7 | GO:0030027 | |
| GeneOntologyCellularComponent | anchoring junction | CORO1C L1CAM TENM2 CLDN10 CLDN8 FRMD4A FNDC1 FAT2 SCN1A CLMP PEAK1 DMD ADGRL3 CDH13 GAB1 | 7.32e-04 | 976 | 125 | 15 | GO:0070161 |
| GeneOntologyCellularComponent | synaptic membrane | ERBB4 L1CAM GRM4 TENM2 ITPR1 SCN1A SCN10A CLMP DMD UTRN ADGRL3 | 7.61e-04 | 583 | 125 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | cell-cell junction | TENM2 CLDN10 CLDN8 FRMD4A FNDC1 FAT2 SCN1A CLMP ADGRL3 CDH13 GAB1 | 8.50e-04 | 591 | 125 | 11 | GO:0005911 |
| GeneOntologyCellularComponent | filopodium | 8.68e-04 | 123 | 125 | 5 | GO:0030175 | |
| MousePheno | abnormal circulating glutathione level | 1.78e-11 | 5 | 101 | 5 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 1.78e-11 | 5 | 101 | 5 | MP:0030653 | |
| MousePheno | glutathionuria | 1.78e-11 | 5 | 101 | 5 | MP:0013730 | |
| MousePheno | increased glutathione level | 1.78e-11 | 5 | 101 | 5 | MP:0012606 | |
| MousePheno | decreased circulating cysteine level | 3.70e-10 | 7 | 101 | 5 | MP:0030626 | |
| MousePheno | decreased cysteine level | 9.81e-10 | 8 | 101 | 5 | MP:0030623 | |
| MousePheno | epididymis hypoplasia | 9.81e-10 | 8 | 101 | 5 | MP:0004932 | |
| MousePheno | nervous | 2.19e-09 | 9 | 101 | 5 | MP:0008912 | |
| MousePheno | failure of copulatory plug deposition | 4.36e-09 | 10 | 101 | 5 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 4.36e-09 | 10 | 101 | 5 | MP:0005148 | |
| MousePheno | ovary hypoplasia | 4.36e-09 | 10 | 101 | 5 | MP:0005158 | |
| MousePheno | abnormal circulating cysteine level | 7.95e-09 | 11 | 101 | 5 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 7.95e-09 | 11 | 101 | 5 | MP:0011130 | |
| MousePheno | increased growth hormone level | 1.12e-08 | 23 | 101 | 6 | MP:0005137 | |
| MousePheno | abnormal cysteine level | 2.19e-08 | 13 | 101 | 5 | MP:0030621 | |
| MousePheno | decreased glutathione level | 2.19e-08 | 13 | 101 | 5 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 2.19e-08 | 13 | 101 | 5 | MP:0012603 | |
| MousePheno | nuclear cataract | 2.51e-08 | 26 | 101 | 6 | MP:0010254 | |
| MousePheno | priapism | 3.39e-08 | 14 | 101 | 5 | MP:0003415 | |
| MousePheno | abnormal copulatory plug deposition | 7.31e-08 | 16 | 101 | 5 | MP:0030982 | |
| MousePheno | decreased spleen red pulp amount | 7.31e-08 | 16 | 101 | 5 | MP:0008477 | |
| MousePheno | failure of superovulation | 1.42e-07 | 18 | 101 | 5 | MP:0031422 | |
| MousePheno | abnormal penile erection | 1.42e-07 | 18 | 101 | 5 | MP:0001379 | |
| MousePheno | oocyte degeneration | 1.42e-07 | 18 | 101 | 5 | MP:0009093 | |
| MousePheno | increased circulating growth hormone level | 1.91e-07 | 19 | 101 | 5 | MP:0005123 | |
| MousePheno | abnormal copulation physiology | 1.91e-07 | 19 | 101 | 5 | MP:0031627 | |
| MousePheno | small vertebrae | 4.26e-07 | 22 | 101 | 5 | MP:0004610 | |
| MousePheno | induced hyperactivity | 5.20e-07 | 42 | 101 | 6 | MP:0008911 | |
| MousePheno | uterus hypoplasia | 5.41e-07 | 23 | 101 | 5 | MP:0001121 | |
| MousePheno | abnormal copulation behavior | 6.79e-07 | 24 | 101 | 5 | MP:0009697 | |
| MousePheno | decreased long bone epiphyseal plate size | 6.92e-07 | 44 | 101 | 6 | MP:0006396 | |
| MousePheno | decreased thyroxine level | 1.70e-06 | 51 | 101 | 6 | MP:0005471 | |
| MousePheno | aminoaciduria | 1.84e-06 | 29 | 101 | 5 | MP:0003311 | |
| MousePheno | abnormal growth hormone level | 3.30e-06 | 57 | 101 | 6 | MP:0003968 | |
| MousePheno | anovulation | 3.60e-06 | 33 | 101 | 5 | MP:0008869 | |
| MousePheno | decreased circulating follicle stimulating hormone level | 4.20e-06 | 34 | 101 | 5 | MP:0002790 | |
| MousePheno | kyphosis | 5.98e-06 | 229 | 101 | 10 | MP:0000160 | |
| MousePheno | diluted coat color | 6.54e-06 | 64 | 101 | 6 | MP:0000371 | |
| MousePheno | abnormal brain wave pattern | 6.54e-06 | 64 | 101 | 6 | MP:0004994 | |
| MousePheno | decreased circulating estradiol level | 7.40e-06 | 38 | 101 | 5 | MP:0005181 | |
| MousePheno | abnormal thyroxine level | 7.84e-06 | 66 | 101 | 6 | MP:0005469 | |
| MousePheno | decreased tertiary ovarian follicle number | 8.44e-06 | 39 | 101 | 5 | MP:0011129 | |
| MousePheno | abnormal long bone epiphyseal plate proliferative zone | 9.33e-06 | 68 | 101 | 6 | MP:0003662 | |
| MousePheno | decreased circulating estrogen level | 1.09e-05 | 41 | 101 | 5 | MP:0003371 | |
| MousePheno | small epididymis | 1.11e-05 | 70 | 101 | 6 | MP:0004930 | |
| MousePheno | abnormal coat/hair pigmentation | L1CAM POLR1C GGTLC2 GGT2P GGT1 GGT3P KIAA1549L SETD5 GGTLC1 MED12L CORIN WDR12 RPRD2 | 1.11e-05 | 424 | 101 | 13 | MP:0002075 |
| MousePheno | abnormal thyroid hormone level | 1.53e-05 | 74 | 101 | 6 | MP:0005468 | |
| MousePheno | decreased follicle stimulating hormone level | 1.55e-05 | 44 | 101 | 5 | MP:0005130 | |
| MousePheno | absent estrous cycle | 1.55e-05 | 44 | 101 | 5 | MP:0009009 | |
| MousePheno | abnormal spine curvature | CDC14C GGTLC2 NEB CDC14B GGT2P GGT1 GGT3P NISCH GGTLC1 HYDIN RAI1 | 1.82e-05 | 318 | 101 | 11 | MP:0004174 |
| MousePheno | increased osteoclast cell number | 1.92e-05 | 77 | 101 | 6 | MP:0004984 | |
| MousePheno | abnormal tertiary ovarian follicle number | 2.15e-05 | 47 | 101 | 5 | MP:0011127 | |
| MousePheno | hindlimb paralysis | 2.22e-05 | 79 | 101 | 6 | MP:0000755 | |
| MousePheno | limb paralysis | 2.95e-05 | 83 | 101 | 6 | MP:0013147 | |
| MousePheno | abnormal circulating estradiol level | 3.54e-05 | 52 | 101 | 5 | MP:0005183 | |
| MousePheno | aciduria | 4.66e-05 | 55 | 101 | 5 | MP:0010028 | |
| MousePheno | abnormal circulating estrogen level | 5.54e-05 | 57 | 101 | 5 | MP:0003369 | |
| MousePheno | abnormal tertiary ovarian follicle morphology | 5.54e-05 | 57 | 101 | 5 | MP:0009363 | |
| MousePheno | disproportionate dwarf | 5.54e-05 | 57 | 101 | 5 | MP:0002427 | |
| MousePheno | abnormal urine amino acid level | 6.55e-05 | 59 | 101 | 5 | MP:0011468 | |
| MousePheno | immotile sperm | 6.55e-05 | 59 | 101 | 5 | MP:0020869 | |
| MousePheno | decreased circulating gonadotropin level | 7.10e-05 | 60 | 101 | 5 | MP:0003363 | |
| MousePheno | decreased circulating testosterone level | 7.10e-05 | 60 | 101 | 5 | MP:0002780 | |
| MousePheno | decreased amino acid level | 7.12e-05 | 97 | 101 | 6 | MP:0014528 | |
| MousePheno | decreased circulating insulin-like growth factor I level | 7.69e-05 | 61 | 101 | 5 | MP:0004701 | |
| MousePheno | impaired ovarian folliculogenesis | 7.69e-05 | 61 | 101 | 5 | MP:0001129 | |
| MousePheno | abnormal superovulation | 1.12e-04 | 66 | 101 | 5 | MP:0009648 | |
| MousePheno | absent corpus luteum | 1.12e-04 | 66 | 101 | 5 | MP:0001134 | |
| MousePheno | pigmentation phenotype | L1CAM POLR1C GGTLC2 GGT2P GGT1 GGT3P KIAA1549L ALMS1 SETD5 GGTLC1 MED12L CORIN WDR12 RPRD2 | 1.52e-04 | 624 | 101 | 14 | MP:0001186 |
| MousePheno | abnormal habituation to a novel odor | 1.54e-04 | 3 | 101 | 2 | MP:0011622 | |
| MousePheno | abnormal vertebral column morphology | CDC14C TM9SF4 GGTLC2 NEB CDC14B GGT2P GGT1 GGT3P WAC SETD5 SULF1 NISCH GGTLC1 DMD HYDIN RAI1 | 1.56e-04 | 787 | 101 | 16 | MP:0004703 |
| MousePheno | abnormal long bone hypertrophic chondrocyte zone | 1.66e-04 | 113 | 101 | 6 | MP:0000165 | |
| MousePheno | abnormal circulating insulin-like growth factor I level | 1.70e-04 | 72 | 101 | 5 | MP:0004700 | |
| MousePheno | abnormal insulin-like growth factor I level | 2.06e-04 | 75 | 101 | 5 | MP:0008831 | |
| MousePheno | paralysis | 2.20e-04 | 119 | 101 | 6 | MP:0000753 | |
| MousePheno | abnormal axial skeleton morphology | CDC14C PRTG ABI3BP TM9SF4 CORO1C WWP2 L1CAM GGTLC2 NEB CDC14B GGT2P GGT1 GGT3P WAC VPS33B SETD5 SULF1 NISCH GGTLC1 PEAK1 DMD HYDIN RAI1 | 2.35e-04 | 1458 | 101 | 23 | MP:0002114 |
| MousePheno | abnormal amino acid derivative level | 2.87e-04 | 125 | 101 | 6 | MP:0021145 | |
| MousePheno | decreased paired-pulse ratio | 3.07e-04 | 4 | 101 | 2 | MP:0014253 | |
| MousePheno | short femur | 3.13e-04 | 127 | 101 | 6 | MP:0003109 | |
| MousePheno | increased pituitary hormone level | 3.26e-04 | 128 | 101 | 6 | MP:0003973 | |
| MousePheno | abnormal osteoclast cell number | 3.26e-04 | 128 | 101 | 6 | MP:0004983 | |
| MousePheno | abnormal circulating testosterone level | 3.50e-04 | 84 | 101 | 5 | MP:0005180 | |
| MousePheno | abnormal circulating androgen level | 3.50e-04 | 84 | 101 | 5 | MP:0009819 | |
| MousePheno | decreased femur size | 3.55e-04 | 130 | 101 | 6 | MP:0030825 | |
| MousePheno | decreased circulating pituitary hormone level | 4.58e-04 | 89 | 101 | 5 | MP:0005118 | |
| MousePheno | abnormal follicle stimulating hormone level | 4.58e-04 | 89 | 101 | 5 | MP:0003967 | |
| MousePheno | enlarged thymus cortex | 5.10e-04 | 5 | 101 | 2 | MP:0013593 | |
| MousePheno | small uterus | 5.33e-04 | 92 | 101 | 5 | MP:0002637 | |
| MousePheno | abnormal testosterone level | 5.33e-04 | 92 | 101 | 5 | MP:0011385 | |
| MousePheno | postnatal growth retardation | PRTG L1CAM IRS1 GGTLC2 NEB GGT2P GGT1 GGT3P SCN1A NISCH GGTLC1 KIF14 CLMP DMD HYDIN RAI1 | 5.51e-04 | 881 | 101 | 16 | MP:0001732 |
| MousePheno | abnormal sexual interaction | 5.88e-04 | 94 | 101 | 5 | MP:0002566 | |
| MousePheno | abnormal ovulation | 6.79e-04 | 97 | 101 | 5 | MP:0001928 | |
| MousePheno | abnormal epididymis morphology | 7.31e-04 | 269 | 101 | 8 | MP:0002631 | |
| MousePheno | abnormal reproductive system development | 7.45e-04 | 99 | 101 | 5 | MP:0003936 | |
| MousePheno | abnormal postnatal growth | PRTG L1CAM IRS1 GGTLC2 NEB GGT2P GGT1 GGT3P SCN1A NISCH GGTLC1 KIF14 CLMP DMD HYDIN RAI1 | 7.55e-04 | 907 | 101 | 16 | MP:0001731 |
| MousePheno | decreased bone mass | 7.80e-04 | 100 | 101 | 5 | MP:0004016 | |
| MousePheno | tonic-clonic seizures | 1.04e-03 | 62 | 101 | 4 | MP:0003997 | |
| MousePheno | small seminiferous tubules | 1.06e-03 | 107 | 101 | 5 | MP:0001153 | |
| MousePheno | ventricular fibrillation | 1.06e-03 | 7 | 101 | 2 | MP:0006110 | |
| MousePheno | abnormal paired-pulse ratio | 1.06e-03 | 7 | 101 | 2 | MP:0014252 | |
| Domain | GGT_peptidase | 5.40e-08 | 7 | 119 | 4 | IPR000101 | |
| Domain | G_glu_transpept | 5.40e-08 | 7 | 119 | 4 | PF01019 | |
| Domain | G_GLU_TRANSPEPTIDASE | 5.40e-08 | 7 | 119 | 4 | PS00462 | |
| Domain | Dystrophin | 4.03e-05 | 2 | 119 | 2 | IPR016344 | |
| Domain | ZF_ZZ_2 | 1.92e-04 | 18 | 119 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.92e-04 | 18 | 119 | 3 | PS01357 | |
| Domain | ZZ | 1.92e-04 | 18 | 119 | 3 | PF00569 | |
| Domain | WW | 2.26e-04 | 47 | 119 | 4 | PF00397 | |
| Domain | Znf_ZZ | 2.27e-04 | 19 | 119 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 2.27e-04 | 19 | 119 | 3 | SM00291 | |
| Domain | WW | 2.45e-04 | 48 | 119 | 4 | SM00456 | |
| Domain | WW_DOMAIN_1 | 3.11e-04 | 51 | 119 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 3.11e-04 | 51 | 119 | 4 | PS50020 | |
| Domain | WW_dom | 3.35e-04 | 52 | 119 | 4 | IPR001202 | |
| Domain | RIH_assoc-dom | 5.94e-04 | 6 | 119 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 5.94e-04 | 6 | 119 | 2 | PF08709 | |
| Domain | RIH_assoc | 5.94e-04 | 6 | 119 | 2 | PF08454 | |
| Domain | RIH_dom | 5.94e-04 | 6 | 119 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 5.94e-04 | 6 | 119 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 5.94e-04 | 6 | 119 | 2 | IPR015925 | |
| Domain | - | 5.94e-04 | 6 | 119 | 2 | 1.25.10.30 | |
| Domain | EF-hand_dom_typ1 | 5.94e-04 | 6 | 119 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 5.94e-04 | 6 | 119 | 2 | IPR015154 | |
| Domain | RYDR_ITPR | 5.94e-04 | 6 | 119 | 2 | PF01365 | |
| Domain | EF-hand_2 | 5.94e-04 | 6 | 119 | 2 | PF09068 | |
| Domain | EF-hand_3 | 5.94e-04 | 6 | 119 | 2 | PF09069 | |
| Domain | UBA-like | 7.41e-04 | 64 | 119 | 4 | IPR009060 | |
| Domain | Trimer_CC | 8.28e-04 | 7 | 119 | 2 | IPR015049 | |
| Domain | DUF1899 | 8.28e-04 | 7 | 119 | 2 | IPR015048 | |
| Domain | Trimer_CC | 8.28e-04 | 7 | 119 | 2 | PF08954 | |
| Domain | DUF1899 | 8.28e-04 | 7 | 119 | 2 | PF08953 | |
| Domain | Coronin | 8.28e-04 | 7 | 119 | 2 | IPR015505 | |
| Domain | DUF1899 | 8.28e-04 | 7 | 119 | 2 | SM01166 | |
| Domain | - | 1.10e-03 | 8 | 119 | 2 | 2.60.40.360 | |
| Domain | Ntn_hydrolases_N | 1.20e-03 | 33 | 119 | 3 | IPR029055 | |
| Domain | PapD-like | 1.41e-03 | 9 | 119 | 2 | IPR008962 | |
| Domain | Na_channel_asu | 1.75e-03 | 10 | 119 | 2 | IPR001696 | |
| Domain | MIR | 1.75e-03 | 10 | 119 | 2 | PF02815 | |
| Domain | Beta-tubulin_BS | 1.75e-03 | 10 | 119 | 2 | IPR013838 | |
| Domain | MIR_motif | 1.75e-03 | 10 | 119 | 2 | IPR016093 | |
| Domain | Na_trans_assoc | 1.75e-03 | 10 | 119 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 1.75e-03 | 10 | 119 | 2 | PF06512 | |
| Domain | MIR | 1.75e-03 | 10 | 119 | 2 | PS50919 | |
| Domain | MIR | 1.75e-03 | 10 | 119 | 2 | SM00472 | |
| Domain | Beta_tubulin | 1.75e-03 | 10 | 119 | 2 | IPR002453 | |
| Domain | TUBULIN_B_AUTOREG | 2.13e-03 | 11 | 119 | 2 | PS00228 | |
| Domain | OA_transporter | 2.55e-03 | 12 | 119 | 2 | IPR004156 | |
| Domain | OATP | 2.55e-03 | 12 | 119 | 2 | PF03137 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 1.24e-08 | 27 | 87 | 6 | MM15908 | |
| Pathway | REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING | 3.30e-08 | 16 | 87 | 5 | MM14680 | |
| Pathway | WP_GLUTATHIONE_AND_ONECARBON_METABOLISM | 6.52e-08 | 35 | 87 | 6 | MM15815 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 1.93e-07 | 22 | 87 | 5 | MM15961 | |
| Pathway | WP_OXYLIPINS_PATHWAYS | 3.09e-07 | 24 | 87 | 5 | MM17249 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 3.84e-07 | 25 | 87 | 5 | MM14858 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 4.73e-07 | 26 | 87 | 5 | MM15190 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 1.65e-06 | 33 | 87 | 5 | MM15963 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 3.41e-06 | 38 | 87 | 5 | MM14600 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 3.89e-06 | 39 | 87 | 5 | MM15695 | |
| Pathway | WP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY | 2.16e-05 | 92 | 87 | 6 | MM15823 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.55e-05 | 203 | 87 | 8 | M5485 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 3.61e-05 | 61 | 87 | 5 | MM14861 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 5.10e-05 | 107 | 87 | 6 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 9.22e-05 | 119 | 87 | 6 | MM15692 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.50e-04 | 130 | 87 | 6 | M27454 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 4.05e-04 | 219 | 87 | 7 | MM14838 | |
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 23615310 | ||
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 11003618 | ||
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 10392451 | ||
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 19850887 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 6.00e-13 | 5 | 127 | 5 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 6.00e-13 | 5 | 127 | 5 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 6.00e-13 | 5 | 127 | 5 | 11089562 | |
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 6.00e-13 | 5 | 127 | 5 | 12225953 | |
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 7775425 | ||
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 9139708 | ||
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 6.00e-13 | 5 | 127 | 5 | 9546365 | |
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 6.00e-13 | 5 | 127 | 5 | 10751614 | |
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 6.00e-13 | 5 | 127 | 5 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 6.00e-13 | 5 | 127 | 5 | 24698228 | |
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 10474818 | ||
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 6.00e-13 | 5 | 127 | 5 | 18063838 | |
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 10940879 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 6.00e-13 | 5 | 127 | 5 | 11095909 | |
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 7641802 | ||
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 9627710 | ||
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 12453183 | ||
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 2891746 | ||
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 6.00e-13 | 5 | 127 | 5 | 12468440 | |
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 6.00e-13 | 5 | 127 | 5 | 8566783 | |
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 30591459 | ||
| Pubmed | 6.00e-13 | 5 | 127 | 5 | 11795900 | ||
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 6.00e-13 | 5 | 127 | 5 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 6.00e-13 | 5 | 127 | 5 | 19760322 | |
| Pubmed | 3.59e-12 | 6 | 127 | 5 | 14634009 | ||
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 3.59e-12 | 6 | 127 | 5 | 8101000 | |
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 3.59e-12 | 6 | 127 | 5 | 8104871 | |
| Pubmed | 3.59e-12 | 6 | 127 | 5 | 11463821 | ||
| Pubmed | 3.59e-12 | 6 | 127 | 5 | 25326709 | ||
| Pubmed | 3.59e-12 | 6 | 127 | 5 | 12163373 | ||
| Pubmed | 3.59e-12 | 6 | 127 | 5 | 22242126 | ||
| Pubmed | 3.59e-12 | 6 | 127 | 5 | 17363454 | ||
| Pubmed | 3.59e-12 | 6 | 127 | 5 | 8663190 | ||
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 1.25e-11 | 7 | 127 | 5 | 32284594 | |
| Pubmed | 1.25e-11 | 7 | 127 | 5 | 36685533 | ||
| Pubmed | 1.25e-11 | 7 | 127 | 5 | 27775020 | ||
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 1.25e-11 | 7 | 127 | 5 | 1968405 | |
| Pubmed | 1.49e-10 | 10 | 127 | 5 | 23863468 | ||
| Pubmed | 1.17e-09 | 14 | 127 | 5 | 18357469 | ||
| Pubmed | 1.46e-09 | 56 | 127 | 7 | 20096683 | ||
| Pubmed | Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. | 4.95e-09 | 18 | 127 | 5 | 17097888 | |
| Pubmed | 4.54e-08 | 27 | 127 | 5 | 18478268 | ||
| Pubmed | Human lung expresses unique gamma-glutamyl transpeptidase transcripts. | 4.76e-08 | 3 | 127 | 3 | 7689219 | |
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 4.76e-08 | 3 | 127 | 3 | 2573352 | |
| Pubmed | Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. | 6.64e-08 | 29 | 127 | 5 | 22424930 | |
| Pubmed | 2.73e-07 | 38 | 127 | 5 | 27820600 | ||
| Pubmed | 3.24e-07 | 322 | 127 | 10 | 26514267 | ||
| Pubmed | ARHGAP32 ERBB4 SHB FAM83B VPS33B NISCH SEMA6A PEAK1 DMD UTRN GAB1 | 4.54e-07 | 421 | 127 | 11 | 36976175 | |
| Pubmed | 5.81e-07 | 44 | 127 | 5 | 16332269 | ||
| Pubmed | A comprehensive analysis of 22q11 gene expression in the developing and adult brain. | 6.52e-07 | 45 | 127 | 5 | 14614146 | |
| Pubmed | 1.40e-06 | 95 | 127 | 6 | 20843830 | ||
| Pubmed | 1.65e-06 | 7 | 127 | 3 | 11860456 | ||
| Pubmed | Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome. | 2.79e-06 | 27 | 127 | 4 | 18468998 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TFEB ARHGAP32 ERBB4 HIVEP2 UBAP2 WWP2 IRS1 FAM83B ALMS1 N4BP2 KIF14 PEAK1 UTRN GAB1 | 3.42e-06 | 861 | 127 | 14 | 36931259 |
| Pubmed | 6.02e-06 | 187 | 127 | 7 | 26460568 | ||
| Pubmed | 1.02e-05 | 12 | 127 | 3 | 15457507 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 10525423 | ||
| Pubmed | In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice. | 1.32e-05 | 2 | 127 | 2 | 28790199 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 26555638 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 25180444 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 25859846 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 19923902 | ||
| Pubmed | G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain. | 1.32e-05 | 2 | 127 | 2 | 7731967 | |
| Pubmed | The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway. | 1.32e-05 | 2 | 127 | 2 | 21502810 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 16710609 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 30672725 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 7962191 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 8021701 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 26974331 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 28453658 | ||
| Pubmed | A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin. | 1.32e-05 | 2 | 127 | 2 | 11801396 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 7987307 | ||
| Pubmed | Comparative analysis of the human dystrophin and utrophin gene structures. | 1.32e-05 | 2 | 127 | 2 | 11861579 | |
| Pubmed | Distinct mechanical properties in homologous spectrin-like repeats of utrophin. | 1.32e-05 | 2 | 127 | 2 | 30914715 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 22284942 | ||
| Pubmed | Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice. | 1.32e-05 | 2 | 127 | 2 | 17889902 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 22438565 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 35557546 | ||
| Pubmed | Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice. | 1.32e-05 | 2 | 127 | 2 | 37626761 | |
| Pubmed | Birth and rapid subcellular adaptation of a hominoid-specific CDC14 protein. | 1.32e-05 | 2 | 127 | 2 | 18547142 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 15565469 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 26516677 | ||
| Pubmed | Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging. | 1.32e-05 | 2 | 127 | 2 | 22209498 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 37108685 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 10694796 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 25280803 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 25242522 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 24337461 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 11297940 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 22388933 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 25642938 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 15703201 | ||
| Interaction | GGT2P interactions | 2.11e-07 | 3 | 121 | 3 | int:GGT2P | |
| Interaction | GGTLC1 interactions | 1.16e-05 | 8 | 121 | 3 | int:GGTLC1 | |
| Interaction | GGT1 interactions | 1.42e-05 | 25 | 121 | 4 | int:GGT1 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 2.26e-09 | 13 | 83 | 5 | 564 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 7.24e-05 | 18 | 83 | 3 | 91 | |
| GeneFamily | WD repeat domain containing|Coronins | 4.31e-04 | 7 | 83 | 2 | 495 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 7.34e-04 | 9 | 83 | 2 | 1203 | |
| GeneFamily | Fibronectin type III domain containing | 8.49e-04 | 160 | 83 | 5 | 555 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 3.53e-06 | 49 | 124 | 5 | MM1287 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | PRTG ERBB4 DCDC1 IRS1 FNDC1 FAT2 KIAA1549L SCN1A MED12L HYDIN | 9.47e-06 | 364 | 124 | 10 | M39057 |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 1.50e-05 | 111 | 124 | 6 | MM1111 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | L1CAM NEB GRM4 ABLIM3 TENM2 RYR2 TUBB3 FAT2 MICU3 KIAA1549L ERAP2 N4BP2 SCN1A HYDIN ADGRL3 CDH13 RAI1 | 1.85e-05 | 1106 | 124 | 17 | M39071 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | ABI3BP ABLIM3 ITPR1 TUBB6 SULF1 AOC3 CLMP DMD NNMT ADGRL3 CDH13 | 2.91e-05 | 505 | 124 | 11 | M39167 |
| Coexpression | GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_DN | 4.65e-05 | 199 | 124 | 7 | M6576 | |
| Coexpression | GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_DN | 4.80e-05 | 200 | 124 | 7 | M6550 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TFEB PRTG IKZF2 CORO1C WWP2 SHB IRS1 SLC48A1 WAC TUBB3 PER3 ALMS1 NISCH NINJ2 ADGRL3 GAB1 | 6.53e-05 | 1102 | 124 | 16 | M2369 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | ARHGAP32 HIVEP2 TENM2 RYR2 ITPR1 FRMD4A KIAA1549L PTPRR SCN1A | 5.45e-09 | 198 | 126 | 9 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.84e-08 | 198 | 126 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.43e-07 | 158 | 126 | 7 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.40e-07 | 169 | 126 | 7 | 605cc2638271803cf1d972ab3fa8f13f89666376 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.40e-07 | 169 | 126 | 7 | 337be3bf485b54afad86e256cb0c4c1d0c2a9a2a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-06 | 189 | 126 | 7 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-06 | 191 | 126 | 7 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-06 | 193 | 126 | 7 | a402e736440684ebe123673b6b0c6fcd8fa057b2 | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.32e-06 | 193 | 126 | 7 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.75e-06 | 152 | 126 | 6 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.61e-06 | 161 | 126 | 6 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.85e-06 | 162 | 126 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.43e-06 | 168 | 126 | 6 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.72e-06 | 169 | 126 | 6 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.64e-06 | 172 | 126 | 6 | bb542f6ca4eb8167129bc84ca1160a54fbb68731 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.64e-06 | 172 | 126 | 6 | aff37b9689b0d30ee7097d997d9588efc475c8fd | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 9.96e-06 | 173 | 126 | 6 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 175 | 126 | 6 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 175 | 126 | 6 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 176 | 126 | 6 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 176 | 126 | 6 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 181 | 126 | 6 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.37e-05 | 183 | 126 | 6 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-05 | 184 | 126 | 6 | c7073d1b2c4fdb154d87678b92a0629c02116972 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-05 | 184 | 126 | 6 | 1ed558a88215b248431c524ea16f13d9022ae98c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.50e-05 | 186 | 126 | 6 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 186 | 126 | 6 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 186 | 126 | 6 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-05 | 186 | 126 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-05 | 187 | 126 | 6 | 173f029dcf32af008f517912f6d110a33a9e98cf | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.65e-05 | 189 | 126 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | moderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.65e-05 | 189 | 126 | 6 | 22a19365782003c18ec8dddcdbfdaa82c4e330f6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 190 | 126 | 6 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.70e-05 | 190 | 126 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.70e-05 | 190 | 126 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 190 | 126 | 6 | 68ba1934b2b3f0cec8efd229fe1db6e8be8a26b0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.70e-05 | 190 | 126 | 6 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 190 | 126 | 6 | 010d7d13a3c16e614c36720ef690a505b9f3f7aa | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.75e-05 | 191 | 126 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.75e-05 | 191 | 126 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.75e-05 | 191 | 126 | 6 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.75e-05 | 191 | 126 | 6 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.75e-05 | 191 | 126 | 6 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Prlr-Inhibitory_Gad1Gad2_Id2.Prlr_(Interneuron,_Neurogliaform3)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.79e-05 | 55 | 126 | 4 | 948f26841f18d2d45f74c7c0c7b5be10737a4f43 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Prlr|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.79e-05 | 55 | 126 | 4 | 616be3c334949ab0264293b9771d494381d74fb4 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Prlr-Inhibitory_Gad1Gad2_Id2.Prlr_(Interneuron,_Neurogliaform3)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.79e-05 | 55 | 126 | 4 | ed14bdb80cf2ff171b0dfc391ac0b150da344992 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.80e-05 | 192 | 126 | 6 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-05 | 193 | 126 | 6 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.91e-05 | 194 | 126 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 194 | 126 | 6 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.91e-05 | 194 | 126 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 194 | 126 | 6 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 1.91e-05 | 194 | 126 | 6 | eaeeb84576270cc3fc59002ba33bff9639bb0b02 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 194 | 126 | 6 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.96e-05 | 195 | 126 | 6 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.96e-05 | 195 | 126 | 6 | 6c9c58322c1df891bb4bab56dacb542c8777bb7d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-05 | 195 | 126 | 6 | eb2003d4f15cad213d17eda8ab7479f5a0c62164 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.96e-05 | 195 | 126 | 6 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.02e-05 | 196 | 126 | 6 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-05 | 196 | 126 | 6 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 196 | 126 | 6 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 197 | 126 | 6 | 398a66c06df63567b176ab2cc85e27837e94d0d9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 197 | 126 | 6 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.08e-05 | 197 | 126 | 6 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 197 | 126 | 6 | 94a7270ea6d4b586f58875c9e4071ce0f683ef7e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 197 | 126 | 6 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 197 | 126 | 6 | 888f3b14133e078570ce4ad73d9a9ee3137f9cac | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-05 | 198 | 126 | 6 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-05 | 198 | 126 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-05 | 198 | 126 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-05 | 198 | 126 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-I_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.20e-05 | 199 | 126 | 6 | 5a002d49a8b84c158f7b4d7a3e78e6a937757bb7 | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.20e-05 | 199 | 126 | 6 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-05 | 199 | 126 | 6 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-05 | 199 | 126 | 6 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-05 | 200 | 126 | 6 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM4|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.26e-05 | 200 | 126 | 6 | 30448a41ca64d6f0fedaff0b7a6670dd33cdf2c5 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.26e-05 | 200 | 126 | 6 | 4f481d87e30195365900acb5d50641a9e7b2f462 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.26e-05 | 200 | 126 | 6 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.26e-05 | 200 | 126 | 6 | 5490393c5f54748f912676e19b58bd1320415a06 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.26e-05 | 200 | 126 | 6 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.26e-05 | 200 | 126 | 6 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.26e-05 | 200 | 126 | 6 | cf720d3973e79ffd4c6e763a7284799ced22a274 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.26e-05 | 200 | 126 | 6 | df821ac12953e44fcfedbbefb35a4976e406ccd6 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 2.26e-05 | 200 | 126 | 6 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.26e-05 | 200 | 126 | 6 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.42e-05 | 143 | 126 | 5 | 28e936c298a45f88d14f0146caf3d5a22d483cd5 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-05 | 145 | 126 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.98e-05 | 146 | 126 | 5 | 86cddd0e7f954547b7ffdccb0329cd5c4b725ac1 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.59e-05 | 149 | 126 | 5 | aedbae2dffa1e880e5c6a146b6d5a135e7f54308 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.80e-05 | 150 | 126 | 5 | 6f7087a051a2f05c5611ff65a945c01736d5ec2b | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.19e-05 | 156 | 126 | 5 | 1a0e081284a99c1b345990775015b8a2fa469496 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.69e-05 | 158 | 126 | 5 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | Posterior_cortex|World / BrainAtlas - Mouse McCarroll V32 | 8.96e-05 | 159 | 126 | 5 | 18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 8.96e-05 | 159 | 126 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.50e-05 | 161 | 126 | 5 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 9.78e-05 | 162 | 126 | 5 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 9.78e-05 | 162 | 126 | 5 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 163 | 126 | 5 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.07e-04 | 165 | 126 | 5 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 2.32e-11 | 7 | 122 | 5 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 6.17e-11 | 8 | 122 | 5 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | ascending aortic diameter | 2.64e-05 | 140 | 122 | 6 | EFO_0021787 | |
| Disease | Neurodevelopmental Disorders | 4.32e-05 | 93 | 122 | 5 | C1535926 | |
| Disease | urate measurement, bone density | ERBB4 NAALADL2 TENM2 ITPR1 FNDC1 SULF1 KIF14 PEAK1 UTRN CDH13 | 2.58e-04 | 619 | 122 | 10 | EFO_0003923, EFO_0004531 |
| Disease | cystatin C measurement | 2.76e-04 | 402 | 122 | 8 | EFO_0004617 | |
| Disease | joint hypermobility measurement | 3.44e-04 | 33 | 122 | 3 | EFO_0007905 | |
| Disease | electrocardiography, PR interval | 3.51e-04 | 7 | 122 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | arabinose measurement | 3.51e-04 | 7 | 122 | 2 | EFO_0021030 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | ERBB4 IKZF2 DCDC1 USP28 TENM2 RYR2 ALMS1 ERAP2 UTRN ADGRL3 CDH13 | 5.03e-04 | 801 | 122 | 11 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | X-21467 measurement | 5.99e-04 | 9 | 122 | 2 | EFO_0020007 | |
| Disease | aortic measurement | 6.34e-04 | 251 | 122 | 6 | EFO_0020865 | |
| Disease | reading and spelling ability | 6.47e-04 | 166 | 122 | 5 | EFO_0005301 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 7.47e-04 | 10 | 122 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 7.47e-04 | 10 | 122 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | ptosis (implicated_via_orthology) | 7.47e-04 | 10 | 122 | 2 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 7.47e-04 | 10 | 122 | 2 | DOID:0112227 (implicated_via_orthology) | |
| Disease | facial paralysis (implicated_via_orthology) | 7.47e-04 | 10 | 122 | 2 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 7.47e-04 | 10 | 122 | 2 | DOID:0090132 (implicated_via_orthology) | |
| Disease | cholesteryl ester 20:4 measurement | 8.07e-04 | 44 | 122 | 3 | EFO_0010348 | |
| Disease | age at menarche | 8.32e-04 | 594 | 122 | 9 | EFO_0004703 | |
| Disease | Cognitive impairment | 9.10e-04 | 11 | 122 | 2 | HP_0100543 | |
| Disease | Cardiomyopathy, Dilated | 1.04e-03 | 48 | 122 | 3 | C0007193 | |
| Disease | Prostatic Neoplasms | 1.07e-03 | 616 | 122 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.07e-03 | 616 | 122 | 9 | C0376358 | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 1.09e-03 | 12 | 122 | 2 | DOID:0050997 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.09e-03 | 12 | 122 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Hepatic fibrosis | 1.11e-03 | 49 | 122 | 3 | HP_0001395 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 1.17e-03 | 50 | 122 | 3 | C1449563 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 1.24e-03 | 51 | 122 | 3 | cv:CN043650 | |
| Disease | monoclonal gammopathy | 1.39e-03 | 53 | 122 | 3 | EFO_0000203 | |
| Disease | N-acetylmethionine measurement | 1.72e-03 | 15 | 122 | 2 | EFO_0021427 | |
| Disease | obesity (implicated_via_orthology) | 2.04e-03 | 215 | 122 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | partial epilepsy | 2.21e-03 | 17 | 122 | 2 | EFO_0004263 | |
| Disease | periodontitis | 2.39e-03 | 223 | 122 | 5 | EFO_0000649 | |
| Disease | sphingosine 1-phosphate measurement | 2.48e-03 | 18 | 122 | 2 | EFO_0800185 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.63e-03 | 447 | 122 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | Intellectual Disability | 2.63e-03 | 447 | 122 | 7 | C3714756 | |
| Disease | Profound Mental Retardation | 2.70e-03 | 139 | 122 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.70e-03 | 139 | 122 | 4 | C0025363 | |
| Disease | Mental deficiency | 2.70e-03 | 139 | 122 | 4 | C0917816 | |
| Disease | biological sex | 2.73e-03 | 230 | 122 | 5 | PATO_0000047 | |
| Disease | hydrocephalus (implicated_via_orthology) | 2.77e-03 | 19 | 122 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | hemifacial microsomia | 2.77e-03 | 19 | 122 | 2 | MONDO_0015398 | |
| Disease | blood urea nitrogen measurement | 2.80e-03 | 452 | 122 | 7 | EFO_0004741 | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 3.09e-03 | 70 | 122 | 3 | EFO_0008082 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 3.38e-03 | 21 | 122 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | Arthrogryposis | 3.38e-03 | 21 | 122 | 2 | C0003886 | |
| Disease | gait measurement | 3.54e-03 | 150 | 122 | 4 | EFO_0007680 | |
| Disease | electroencephalogram measurement | 3.61e-03 | 74 | 122 | 3 | EFO_0004357 | |
| Disease | Nonsyndromic genetic hearing loss | 3.89e-03 | 76 | 122 | 3 | cv:C5680182 | |
| Disease | coronary artery disease | ERBB4 HIVEP2 DOCK8 CORO1C FAM83B FNDC1 VPS33B WDR12 RPRD2 ADGRL3 CDH13 RAI1 | 3.97e-03 | 1194 | 122 | 12 | EFO_0001645 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKSIVYKSPHTTIYN | 471 | A8K979 | |
| STLQHPDYLQEYSTK | 1251 | Q15303 | |
| YHSQLDVRSSTPTSY | 411 | O94929 | |
| VYNIHSRTVTRYPAN | 56 | O95415 | |
| LYSRPKSASNVHYFS | 61 | O60729 | |
| PALATKQTYVTYTNH | 896 | Q14833 | |
| HLIYKTSVYNTQPSS | 881 | Q7Z2Y8 | |
| GYTSRNPQSYHLLSK | 316 | Q0P651 | |
| LTSNYIPSYLNNHER | 1241 | Q9HAR2 | |
| YSQHTEKPSIFYQQS | 1381 | Q8TCU4 | |
| SSFYSHTEKPNISYQ | 1756 | Q8TCU4 | |
| YVHYLNTFSSKEPQR | 301 | Q9ULV4 | |
| YHKPSVFTRVSNYID | 246 | P08217 | |
| SPNKVPYYINHETQT | 3066 | P11532 | |
| HLYAPLYQEASRNTS | 1761 | Q96M86 | |
| SLQHQTIRYSVYKDP | 506 | P55290 | |
| DLNPFYQKYSSRTQH | 821 | Q7Z478 | |
| FSISDNNKTPRYTYN | 181 | P78369 | |
| LYSRPKSASNVHYFS | 31 | A4D256 | |
| SATPRYLYLASNHSN | 581 | Q16853 | |
| RAQKQPGHTNYSSYS | 1521 | Q7Z5J4 | |
| SQISDHTTHPISYYK | 356 | A6NGU5 | |
| FSSYVYQHIKSLPAN | 471 | M0R2J8 | |
| HYASQTTVYEKLAAP | 416 | Q15058 | |
| KSSSRVDEYPQSNIY | 1776 | Q86YW9 | |
| LKAAYSFYNVHTQTP | 416 | P30419 | |
| KPQKHESTSSYNYRV | 1171 | Q14643 | |
| QSSNDKYYTHSKTLP | 36 | Q86Z02 | |
| SSLYNLPRSYSHDVL | 256 | Q13480 | |
| HDSKQTPYYQRNTKR | 791 | A6NM62 | |
| KYSYKSPQLSVHVTD | 126 | P20138 | |
| PAQEAAKIYHTNYVR | 6 | Q8TAF8 | |
| DPGNSKHYVYSTLTR | 676 | Q5T0W9 | |
| SPYSSYLQQESRSKA | 701 | P56645 | |
| SHYNATIYENSSPKT | 36 | Q9NYQ8 | |
| YHKPVQASYFETLRQ | 131 | O95989 | |
| KESQQYYHSLAVRQS | 1366 | Q9H792 | |
| TSKDTYLSHFNPRDY | 6 | P40261 | |
| RAQISDDTTHPISYY | 11 | Q9BX51 | |
| QSTHKQVLTLYNPYE | 31 | Q9UJG1 | |
| NQTSTTLKLSPYVHY | 671 | P32004 | |
| RAQISDDTTHPISYY | 11 | Q14390 | |
| FQTAEVAYYSPTTRH | 516 | Q6ZVL6 | |
| QLYGYHSPTNSVLKT | 286 | Q86XE3 | |
| VLSYYSLPRSFKHTQ | 761 | P35568 | |
| YTKYDPTHFILNTAS | 116 | Q9P0S3 | |
| KPYQSSQARSDYHVT | 1621 | A7KAX9 | |
| SQARSDYHVTQLQPY | 1626 | A7KAX9 | |
| ISSAYSQVYHPNRIE | 351 | Q9UKS7 | |
| AITRHQSLTDPTSYY | 96 | Q6P1K1 | |
| IAPQKIYRHSYHSSS | 56 | Q15256 | |
| RPLYNSDKVIAYSVH | 441 | Q2VWP7 | |
| STPINSKKHIQRDYY | 471 | Q8IZE3 | |
| QKFVPTDYASYTQEH | 56 | Q5VZV1 | |
| TYQLYSRTSGKHVQV | 71 | P55075 | |
| YLHSQSQPSSQYRIK | 821 | Q9P2Q2 | |
| YTPSDGTQKVTYLVH | 156 | O75874 | |
| ANAVYSKYNITPSSV | 3161 | Q4G0P3 | |
| SSYLNSVERYDPKTN | 376 | Q9Y2M5 | |
| LQEVYTAVTYHNKSP | 611 | Q8NF50 | |
| SNRSLPAKYKHEYVS | 61 | Q96LM5 | |
| HTYKVQRLNESTSYK | 1006 | Q9Y2H6 | |
| TSRPVEHYNIAYGKS | 66 | Q4ZHG4 | |
| HLSYLTEYRSYNPQK | 306 | Q92828 | |
| TSYPNYFGHRTQKEA | 471 | Q9Y5Q5 | |
| IYASPDKRNQTHYAL | 286 | Q6P179 | |
| PYNSSTIRSIYHVRN | 141 | Q9UK59 | |
| TTEYQPILSSYSHRA | 866 | Q5VT52 | |
| DKHNIYSIYNTKSSR | 3176 | Q92736 | |
| SYTQPRYEKELNHTQ | 246 | Q8NAC3 | |
| SQISDHTTHPISYYK | 356 | P36268 | |
| SFIYLRPKTNYTSSQ | 256 | Q8NGX5 | |
| SYNPVTHIYTAQDVK | 226 | P06865 | |
| KAVLEQGPSSHYYTT | 51 | Q9NZG7 | |
| RYQHTATSSPNRDYV | 251 | P0C091 | |
| SISHNKVPYYINHQT | 2821 | P46939 | |
| YIRSTPTENELKFHY | 16 | Q9UL33 | |
| KVQSYLENPTSYHLQ | 71 | P19484 | |
| SYLVRNSQTSKHDYS | 431 | Q15464 | |
| QKRHPDINASAYSAY | 596 | Q8NBJ9 | |
| QTSIPDYFYDRKSQT | 446 | Q9H7E2 | |
| VSKIITHPEYNSREY | 121 | Q7RTY7 | |
| SPAVNEKSVYSTHNY | 31 | Q9C0A6 | |
| INTQADPYTTTKRYN | 111 | Q9UIB8 | |
| YTYHDNSFRIASIKP | 2091 | Q9NT68 | |
| DSQPYQALKYSSKSH | 21 | Q9BTA9 | |
| SSDPNELYVNHKVYT | 156 | O15160 | |
| IARIPYTKSQTEAHY | 251 | Q15391 | |
| LNYLKDTFTHTPSYD | 256 | Q8IUC4 | |
| NRLTYEKRYSSPHQS | 541 | P35498 | |
| RYSIPSHRTTQKSYH | 196 | P56748 | |
| KVVITYSSRHVYNNL | 61 | Q9H6B4 | |
| YSSRHVYNNLTEEQK | 66 | Q9H6B4 | |
| SKLREYQQYHPSLTC | 56 | Q8WTT0 | |
| HNLKTQLFSQSAYYP | 111 | Q6X4T0 | |
| YLVNITEYRASHSTP | 226 | A0A494C1R9 | |
| SYDQSSVHNRIPYQS | 616 | Q5T6F2 | |
| YLVNITEYRASHSTP | 226 | P0CV99 | |
| LPNGRVYYVDHNTKT | 311 | O00308 | |
| LPYVESSSHLKVQYN | 236 | Q6ZTK2 | |
| DPTKENQLYFTYSVH | 241 | Q92544 | |
| YNESSSQKYVPRAAL | 51 | Q9BUF5 | |
| TTNYSSHRKPDIYIN | 286 | Q9Y5Y9 | |
| YSHLVSVGYDTTKPN | 41 | Q9NYW8 | |
| YKRSYPTNSLTRSHQ | 916 | Q9H2E6 | |
| LIKYQRTHTGEQPYT | 391 | Q92670 | |
| TVSYQGTKPVSYHER | 456 | Q9NYB5 | |
| YRYSKETHINPSENS | 121 | Q9NPD5 | |
| TSATHEYRETPYQKA | 391 | Q9NPI9 | |
| NYELIHSSRVKFTYP | 1306 | Q9Y2I1 | |
| IAKIYQQNPEAYSHT | 176 | O75191 | |
| YNEASSHKYVPRAIL | 51 | Q13509 | |
| LNYLKETFTHTPSYD | 171 | A8MT19 | |
| YSRLYQLAKETPTSH | 806 | Q96RU2 | |
| TLSQHYRTHTGEKPY | 566 | Q06730 | |
| PSYLTQHYQLHSQEK | 506 | Q9NZV7 | |
| SQYSRDQKEPPSHQY | 101 | Q70CQ3 | |
| DNKLYSYRYSPTTSH | 406 | Q9GZL7 | |
| KIQSTYDQDHTVPAY | 221 | Q7Z7G0 | |
| SSLNPAYSQYSQKSI | 156 | P31629 | |
| KLYPNASQHITPSYN | 236 | Q8IWU6 | |
| YIYSKKSSTSRRQHP | 721 | Q8IYH5 | |
| RSLKTQYLQSYGPEH | 416 | Q9H267 | |
| TTHQRTHTREQPYEY | 371 | B1APH4 | |
| TCEYYRKASPHILSQ | 96 | B6A8C7 | |
| HKRGKPYQSSNYSID | 416 | Q8TF47 | |
| PYQSSNYSIDFKHST | 421 | Q8TF47 | |
| HPTSYIRTKTYECNI | 261 | Q49AA0 | |
| AQISDDTTHPISYYK | 356 | P19440 | |
| YITHYTRSAPKSNRC | 106 | Q58DX5 | |
| VARNTHNLYSYPTKH | 1386 | Q8NEV4 | |
| SSVQSDKKYNYPQSH | 811 | Q86UW6 | |
| TEYASDQKYRQHPSN | 2196 | P20929 |